Answers are grounded in this paper and cite their sources.
ADAM 33, the latest of the ADAM proteins to be described, has been identified as a major susceptibility gene in asthma linked to bronchial hyperresponsiveness. It provides an important breakthrough in our understanding of this complex disorder and its variable clinical and physiological presentations.
No takes yet. Share an insight, caveat, or question.
Stephen T. Holgate (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: